Brinder Vij

404 total citations
10 papers, 273 citations indexed

About

Brinder Vij is a scholar working on Psychiatry and Mental health, Physiology and Pharmacology. According to data from OpenAlex, Brinder Vij has authored 10 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 4 papers in Physiology and 3 papers in Pharmacology. Recurrent topics in Brinder Vij's work include Migraine and Headache Studies (7 papers), Sympathectomy and Hyperhidrosis Treatments (3 papers) and Ophthalmology and Eye Disorders (3 papers). Brinder Vij is often cited by papers focused on Migraine and Headache Studies (7 papers), Sympathectomy and Hyperhidrosis Treatments (3 papers) and Ophthalmology and Eye Disorders (3 papers). Brinder Vij collaborates with scholars based in United States. Brinder Vij's co-authors include Vincent T. Martin, Stewart J. Tepper, Mark J. Stillman, Ann Vincent, Jennifer S. Kriegler, Arya B. Mohabbat, Mary O. Whipple, Judith Scheman, Edward C. Covington and Manu Mathews and has published in prestigious journals such as Neurology, Pain and Journal of the American Geriatrics Society.

In The Last Decade

Brinder Vij

10 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brinder Vij United States 8 204 69 67 62 52 10 273
Simon Law United Kingdom 5 196 1.0× 104 1.5× 90 1.3× 15 0.2× 53 1.0× 5 251
Chanee Lynch United States 6 72 0.4× 101 1.5× 14 0.2× 36 0.6× 27 0.5× 12 277
Sarah Vollbracht United States 8 258 1.3× 76 1.1× 124 1.9× 29 0.5× 25 0.5× 17 295
L Pageler Germany 9 362 1.8× 190 2.8× 253 3.8× 20 0.3× 31 0.6× 17 425
A B Danilov Russia 10 114 0.6× 63 0.9× 32 0.5× 13 0.2× 19 0.4× 47 237
Junya Mu China 12 118 0.6× 26 0.4× 28 0.4× 67 1.1× 35 0.7× 21 306
Andreas Peikert Germany 8 364 1.8× 198 2.9× 215 3.2× 11 0.2× 30 0.6× 11 491
Shiori Sugawara Japan 12 43 0.2× 169 2.4× 38 0.6× 13 0.2× 23 0.4× 27 313
Erika Ivanna Araya Brazil 10 65 0.3× 146 2.1× 95 1.4× 8 0.1× 21 0.4× 18 299
Chiara Lupi Italy 8 240 1.2× 76 1.1× 137 2.0× 11 0.2× 9 0.2× 12 297

Countries citing papers authored by Brinder Vij

Since Specialization
Citations

This map shows the geographic impact of Brinder Vij's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brinder Vij with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brinder Vij more than expected).

Fields of papers citing papers by Brinder Vij

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brinder Vij. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brinder Vij. The network helps show where Brinder Vij may publish in the future.

Co-authorship network of co-authors of Brinder Vij

This figure shows the co-authorship network connecting the top 25 collaborators of Brinder Vij. A scholar is included among the top collaborators of Brinder Vij based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brinder Vij. Brinder Vij is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Garg, Shuchita, et al.. (2020). Erenumab: A novel calcitonin gene-related peptide receptor antagonist developed specifically for migraine prevention. Journal of Anaesthesiology Clinical Pharmacology. 36(1). 104–104. 8 indexed citations
2.
Ali, Ashhar, Jennifer S. Kriegler, Stewart J. Tepper, & Brinder Vij. (2018). New Daily Persistent Headache (NDPH) & OnabotulinumtoxinA Therapy (P3.114). Neurology. 90(15_supplement). 1 indexed citations
3.
Ashina, Sait, et al.. (2018). Diagnosis and Treatment of Primary Headache Disorders in Older Adults. Journal of the American Geriatrics Society. 66(12). 2408–2416. 13 indexed citations
4.
Ali, Ashhar, Jennifer S. Kriegler, Stewart J. Tepper, & Brinder Vij. (2018). New Daily Persistent Headache and OnabotulinumtoxinA Therapy. Clinical Neuropharmacology. 42(1). 1–3. 17 indexed citations
6.
Martin, Vincent T. & Brinder Vij. (2016). Diet and Headache: Part 1. Headache The Journal of Head and Face Pain. 56(9). 1543–1552. 69 indexed citations
7.
Tariq, Nauman, et al.. (2016). Long‐Term Outcomes and Clinical Characteristics of Hypnic Headache Syndrome: 40 Patients Series From a Tertiary Referral Center. Headache The Journal of Head and Face Pain. 56(4). 717–724. 16 indexed citations
8.
Martin, Vincent T. & Brinder Vij. (2016). Diet and Headache: Part 2. Headache The Journal of Head and Face Pain. 56(9). 1553–1562. 60 indexed citations
9.
Vij, Brinder, Mary O. Whipple, Stewart J. Tepper, et al.. (2015). Frequency of Migraine Headaches in Patients With Fibromyalgia. Headache The Journal of Head and Face Pain. 55(6). 860–865. 44 indexed citations
10.
Mathews, Manu, et al.. (2014). (540) High dose opioid weaning within the context of a chronic pain rehabilitation program. Journal of Pain. 15(4). S111–S111. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026